Literature DB >> 14534708

Alteration in the metastatic potential of ovarian cancer cells by transfection of the antisense gene of beta-1,4-galactosyltransferase.

Hiroshi Yamashita1, Kaneyuki Kubushiro, Jun Ma, Takuma Fujii, Katsumi Tsukazaki, Masao Iwamori, Shiro Nozawa.   

Abstract

beta-1,4-galactosyltransferase (beta-1,4-GT) has been reported to be activated in ovarian carcinoma cells and an isoform of this enzyme has been used as a tumor marker for ovarian cancer. The present study was undertaken to clarify how beta-1,4-GT affected the cell biological characteristics of ovarian cancer. To this end, we transfected an ovarian tumor cell line with an antisense gene of beta-1,4-GT. Proliferative potential and morphology of the cells transfected with the antisense gene did not differ from those of the control cells. Adhesive potential to the constituents of extracellular matrix was reduced in the antisense gene transfectants. In a nude mouse, the number of peritoneal dissemination foci of the antisense transfectants was smaller than that of the control cells. These results indicated that beta-1,4-GT is closely related to the invasive and metastatic potentials of ovarian cancer while it is not involved in the proliferative potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534708

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Lipid sorting by ceramide structure from plasma membrane to ER for the cholera toxin receptor ganglioside GM1.

Authors:  Daniel J-F Chinnapen; Wan-Ting Hsieh; Yvonne M te Welscher; David E Saslowsky; Lydia Kaoutzani; Eelke Brandsma; Ludovic D'Auria; Hyejung Park; Jessica S Wagner; Kimberly R Drake; Minchul Kang; Thomas Benjamin; M David Ullman; Catherine E Costello; Anne K Kenworthy; Tobias Baumgart; Ramiro H Massol; Wayne I Lencer
Journal:  Dev Cell       Date:  2012-09-11       Impact factor: 12.270

2.  Increased B4GALT1 expression is associated with platelet surface galactosylation and thrombopoietin plasma levels in MPNs.

Authors:  Christian A Di Buduo; Silvia Giannini; Vittorio Abbonante; Vittorio Rosti; Karin M Hoffmeister; Alessandra Balduini
Journal:  Blood       Date:  2021-04-15       Impact factor: 22.113

3.  Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer.

Authors:  Rachel Topno; Ibha Singh; Manoj Kumar; Pallavi Agarwal
Journal:  BMC Cancer       Date:  2021-03-04       Impact factor: 4.430

4.  A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells.

Authors:  Razan Sheta; Christina M Woo; Florence Roux-Dalvai; Frédéric Fournier; Sylvie Bourassa; Arnaud Droit; Carolyn R Bertozzi; Dimcho Bachvarov
Journal:  J Proteomics       Date:  2016-04-17       Impact factor: 4.044

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.